| Literature DB >> 31613041 |
Terry Shing-Bong Lou1, Scott W Bagley2, Michael C Willis1.
Abstract
A series of low-molecular-weight, compact, and multifunctional cyclic alkenylsulfonyl fluorides were efficiently prepared from the corresponding alkenyl triflates. Palladium-catalyzed sulfur dioxide insertion using the surrogate reagent DABSO effects sulfinate formation, before trapping with an F electrophile delivers the sulfonyl fluorides. A broad range of functional groups are tolerated, and a correspondingly large collection of derivatization reactions are possible on the products, including substitution at sulfur, conjugate addition, and N-functionalization. Together, these attributes suggest that this method could find new applications in chemical biology.Entities:
Keywords: fluoride; homogeneous catalysis; multifunctional reagents; palladium; sulfur
Year: 2019 PMID: 31613041 PMCID: PMC6972694 DOI: 10.1002/anie.201910871
Source DB: PubMed Journal: Angew Chem Int Ed Engl ISSN: 1433-7851 Impact factor: 15.336
Scheme 1Common strategies for sulfonyl fluoride synthesis and the approach and reagents reported here.
Selected optimization studies.[a]
|
Entry |
X |
Variation in step 1 |
Solvent for step 2 |
Yield of |
|---|---|---|---|---|
|
1 |
I |
as above |
|
17 % |
|
2 |
I |
1 h |
|
37 % |
|
3 |
I |
1 h |
MeCN |
56 % |
|
4 |
Br |
PdCl2(AmPhos)2, 1 h |
MeCN |
52 % |
|
5 |
OTf |
1 h |
MeCN |
36 % |
|
6 |
OTf |
PdCl2(AmPhos)2, 1 h |
MeCN |
56 % |
|
7 |
OTf |
PdCl2(AmPhos)2, 1 h |
EtOAc |
67 % (70 %)[b] |
|
8 |
OTf |
PdCl2(AmPhos)2, 1 h |
|
54 % |
|
| ||||
[a] Reaction conditions: (step 1) Alkenyl (pseudo)halide (0.3 mmol, 1 equiv), DABSO (0.6 equiv), Et3N (3 equiv), Pd(OAc)2 (5 mol %), PAd2(n‐Bu) (7.5 mol %), i‐PrOH [0.25 m], 75 °C, 16 h; (step 2) NFSI (1.5 equiv), solvent [0.25 m], rt, 1 h. Yields determined by 19F‐NMR spectroscopy with internal standard. [b] Yield of isolated product.
Scope with respect to the cyclic alkenyl sulfonyl fluorides.[a]
|
|
[a] Reaction conditions: Alkenyl triflate 3 (0.3 mmol, 1 equiv), DABSO (0.6 equiv), Et3N (3 equiv), PdCl2(AmPhos)2 (5 mol %), i‐PrOH [0.25 m], 75 °C, 0.5–10 h; then NFSI (1.5 equiv), EtOAc [0.25 m], rt, 1 h. [b] Step 1: 80 °C. [c] Step 1: μW, 95 °C. [d] Step 2: DIPEA (3 equiv) was added after solvent switch and prior to the addition of NFSI. [e] Step 1: PdCl2(AmPhos)2 (5 mol %), DABSO (1 equiv), Et3N (3 equiv), i‐PrOH/1,4‐dioxane (2:1) [0.25 m], 80 °C, 0.5–1.5 h. [f] 96 % recovery of biphenyl triflate.
Scheme 2Functionalization of alkenylsulfonyl fluorides. Reaction conditions: Unless specified, 1 equiv of alkenylsulfonyl fluoride 5 was used. [a] X=CHPh; phenol (1.1 equiv), Cs2CO3 (2 equiv), CH3CN [0.2 m], rt, air, 1 h. [b] X=CHPh; pyrrolidine (5 equiv), CH3CN [0.1 m], 70 °C, air, 3 h. [c] X=NPG; aniline (2.2 equiv), Ca(NTf2)2 (1.1–2.0 equiv), t‐amyl‐OH [0.2 m], 60 °C, 16 h. [d] X=NPG; thiol (1.1 equiv), DBU (10 mol %), DCM [0.2 m], air, rt, 1–2 h. [e] X=C(OCH2CH2O); Pd/C (30 mol %), EtOAc [0.2 m], H2 (balloon), 40 °C, 24 h. [f] X=NBoc; HCl (4 N in dioxane) (10 equiv), 1,4‐dioxane [0.2 m], rt, 16 h. [g] X=NBoc; 20 % (v/v) TFA in DCM [0.1 m], rt, 30 min. [h] X=NBn; propargyl chloroformate (1.8 equiv), CHCl3 [0.33 m], −20 °C to 60 °C, 2 h. [i] Benzyl azide (1.1 equiv), CuSO4⋅5 H2O (5 mol %), sodium ascorbate (10 mol %), t‐BuOH/H2O (1:1) [0.23 m], air, 16 h. [j] Aldehyde (3 equiv), Et3N (1 equiv), NaBH(OAc)3 (3 equiv), DCM [0.2 m], rt, 16 h. [k] 13 (1.1 equiv), Biotin (1.0 equiv), HATU (1.05 equiv), Et3N (2.5 equiv), DMF [0.08 m], N2, rt, 16 h. [l] Et3N (1 equiv), PhNCO or PhNCS (1 equiv), THF [0.2 m], rt, 16 h. [m] Et3N (1 equiv), FITC isomer I (1 equiv), THF [0.2 m], rt, 16 h. [n] Boc‐Phe‐OH (1 equiv), Et3N (3 equiv), T3P (50 % in EtOAc) (2 equiv), DMF [0.1 m], 0 °C, 16 h. PG=protecting group, DBU=1,8‐diazabicyclo[5.4.0]undec‐7‐ene, Boc=tert‐butyloxycarbonyl, DCM=dichloromethane, TFA=trfluoroacetic acid, DMF=dimethylformamide, THF=tetrahydrofuran